Cardiovascular autonomic neuropathy studied by a laser-doppler blood flowmeter in hemodialysis patients

Internal Medicine

Volumn 49, Issue 24, 2010, Pages 2669-2675

  Okano, Kazuhiro ^a,b   Tsuruta, Yuki ^a   Yamashita, Tetsuri ^a   Echida, Yoshihisa ^a   Kabaya, Takashi ^b   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Minami Senju Hospital   (Japan)

Author keywords

ABI; Autonomic neuropathy; Laser Doppler blood flowmeter; Periflux blood flow; PWV

Indexed keywords

PLACEBO; SARPOGRELATE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BLOOD FLOW VELOCITY; BLOOD FLOWMETRY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HEMODIALYSIS; HEMODYNAMIC MONITORING; HUMAN; KIDNEY FAILURE; LASER DOPPLER FLOWMETRY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VALSALVA MANEUVER;

ADULT; AGED; AGED, 80 AND OVER; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD FLOW VELOCITY; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 78650337455     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3884     Document Type: Article

References (33)

1. Savica V, Musolino R, Di Leo R, Santoro D, Vita G, Bellinghieri G. Autonomic dysfunction in uremia. Am J Kidney Dis 38: S118-S121, 2001.
2. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66: 1212-1220, 2004.
3. Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A. Cardiac changes in uremia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant 5: 93-97, 1990.
4. Rostand SG, Brunzell JD, Cannon RO 3rd, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol 2: 1053-1062, 1992.
5. Campese VM. Orthostatic hypotension: idiopathic and uremic. Kidney Int 25: S152-S155, 1988.
6. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 20: 246-253, 1981.
7. Converse RL Jr, Jacobsen TN, Jost CM, et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 90: 1657-1665, 1992.
8. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. BMJ (Clin Res Ed) 285: 916-918, 1982.
9. Röckel A, Hennemann H, Sternagel-Haase A, Heidland A. Uremic sympathetic neuropathy after haemodialysis and transplantation. Eur J Clin Invest 9: 23-27, 1979.
10. Martin GJ, Magid NM, Myers G, et al. Heart rate variability and sudden death secondary to coronary artery disease during ambulatory electrocardiographic monitoring. Am J Cardiol 60: 86-89, 1987.
11. Gottsater A, Ryden-Ahlgren A, Szelag B. Cardiovascular auto-nomic neuropathy associated with carotid atherosclerosis in Type 2 diabetic patients. Diabet Med 20: 495-499, 2003.
12. Okada M, Matsuto T, Satoh S, et al. Role of pulse wave velocity for assessing autonomic nervous system activities in reference to heart rate variability. Med Inform (London) 21: 81-90, 1996.
13. Niwayama J, Sanaka T. Development of a new method for monitoring blood purification: the blood flow analysis of the head and foot by laser Doppler blood flowmeter during hemodialysis. Hemodial Int 9: 56-62, 2005.
14. Niwayama J, Sato T, Kurosawa T, et al. Prediction method for decreases in blood pressure during hemocatharsis therapy by arterio-lar blood flow measurement. J Artif Organs 10: 36-41, 2007.
15. Kido M, Takeuchi S, Hayashida S, Urabe K, Sawada R, Furue M. Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed mi-crowireless laser Doppler flowmeter and arm-raising test. Br J Dermatol 157: 690-697, 2007.
16. Oimomi M, Hatanaka H, Maeda Y, et al. Autonomic nervous function determined by changes of periflux blood flow in the aged. Arch Gerontol Geriatr 5: 159-163, 1986.
17. Oimomi M, Nishimoto S, Matsumoto S, Hatanaka H, Ishikawa K, Baba S. Evaluation of periflux blood flow measurement in diabetic patients with autonomic neuropathy. Diabetes Res Clin Pract 1: 81-85, 1985.
18. Murata K, Araki S. Assessment of autonomic neurotoxicity in occupational and environmental health as determined by ECG R-R interval variability: a review. Am J Ind Med 30: 155-163, 1996.
19. Munakata M, Ito N, Nunokawa T, Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 16: 653-657, 2003.
20. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproduci-bility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25: 359-364, 2002.
21. Tomiyama H, Yamashita A, Arai T, et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. Atherosclerosis 166: 303-309, 2003.
22. Nishimura M, Hashimoto T, Kobayashi H, et al. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant 19: 2532-2538, 2004.
23. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant 20: 1140-1147, 2005.
24. Chuang SY, Chen CH, Cheng CM, Chou P. Combined use of brachial-ankle pulse wave velocity and ankle-brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol 98: 99-105, 2005.
25. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis 172: 95-105, 2004.
26. Robinson TG, Carr SJ. Cardiovascular autonomic dysfunction in uremia. Kidney Int 62: 1921-1932, 2002.
27. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001.
28. Nakao M, Nomura K, Karita K, Nishikitani M, Yano E. Relationship between brachial-ankle pulse wave velocity and heart rate variability in young Japanese men. Hypertens Res 27: 925-931, 2004.
29. Goernig M, Schroeder R, Roth T, et al. Peripheral arterial disease alters heart rate variability in cardiovascular patients. Pacing Clin Electrophysiol 31: 858-862, 2008.
30. Ito K, Notsu T. Effect of sarpogrelate hydrochloride (MCI-9042) on peripheral circulation of chronic arterial occlusive disease. J Clin Ther Med 7: 1243-1251, 1991.
31. Knowles ID, Ramage AG. Evidence for a role for central 5-HT2B as well as 5-HT2A receptors in cardiovascular regulation in anesthetized rats. Br J Pharmacol 128: 530-542, 1999.
32. Nishizawa Y, Nishizawa Y, Yoshioka FS. Efficacy of a selective antagonist of 5-HT2A receptor, sarpogrelate hydrochloride, compared with prostaglandin I2 derivative, beraprost sodium, on painful diabetic neuropathy in patients with type 2 diabetic mellitus in prospective randomized well-controlled comparative study. Chronic Pain 24: 149-158, 2005.
33. Malyszko J, Urano T, Knofler R, et al. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thromb Res 75: 569-576, 1994.